ACE up the sleeve – are vascular patients medically optimized
Author(s) -
A P Coveney,
Gordon C. O’Brien,
Greg Fulton
Publication year - 2011
Publication title -
vascular health and risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.892
H-Index - 68
eISSN - 1178-2048
pISSN - 1176-6344
DOI - 10.2147/vhrm.s15484
Subject(s) - medicine , aspirin , specialty , medical prescription , angiotensin receptor blockers , statin , warfarin , population , vascular disease , ace inhibitor , clopidogrel , angiotensin converting enzyme , emergency medicine , family medicine , atrial fibrillation , nursing , blood pressure , environmental health
To examine the current medical management of arteriopathic patients attending a vascular surgical service at a university teaching hospital over a 6-month period. The prescribing of antiplatelets, statins, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers and beta-blockers was specifically examined. Vascular patients are often under the care of multiple specialties, and therefore the influence of different medical specialties on the patients' medical management was also examined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom